Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Julphar
McKinsey
Federal Trade Commission
AstraZeneca
Teva
Cerilliant
Moodys
Covington
Cantor Fitzgerald

Generated: February 22, 2018

DrugPatentWatch Database Preview

Ertapenem sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for ertapenem sodium and what is the scope of ertapenem sodium patent protection?

Ertapenem sodium
is the generic ingredient in one branded drug marketed by Merck Sharp Dohme and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for ertapenem sodium. One supplier is listed for this compound.
Pharmacology for ertapenem sodium
Ingredient-typeCarbapenems
Drug ClassPenem Antibacterial

US Patents and Regulatory Information for ertapenem sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck Sharp Dohme INVANZ ertapenem sodium INJECTABLE;INTRAMUSCULAR, IV (INFUSION) 021337-001 Nov 21, 2001 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ertapenem sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme INVANZ ertapenem sodium INJECTABLE;INTRAMUSCULAR, IV (INFUSION) 021337-001 Nov 21, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme INVANZ ertapenem sodium INJECTABLE;INTRAMUSCULAR, IV (INFUSION) 021337-001 Nov 21, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme INVANZ ertapenem sodium INJECTABLE;INTRAMUSCULAR, IV (INFUSION) 021337-001 Nov 21, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme INVANZ ertapenem sodium INJECTABLE;INTRAMUSCULAR, IV (INFUSION) 021337-001 Nov 21, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
UBS
Cantor Fitzgerald
Fish and Richardson
Baxter
Boehringer Ingelheim
Merck
Cerilliant
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot